Works matching IS 03922936 AND DT 2023 AND VI 44 AND IP 1


Results: 15
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.

    Published in:
    European Journal of Gynaecological Oncology, 2023, v. 44, n. 1, p. 17, doi. 10.22514/ejgo.2023.002
    By:
    • Ghezelayagh, Talayeh S.;
    • Wu, Emily S.;
    • Barber, Emma L.;
    • Dao, Minh D.;
    • Zsiros, Emese;
    • Urban, Renata R.;
    • Gray, Heidi J.;
    • Goff, Barbara A.;
    • Shah, Chirag A.;
    • Neubauer, Nikki L.;
    • Dai, James Y.;
    • Tanyi, Janos L.;
    • Liao, John B.
    Publication type:
    Article
    15